Stock ORY ORYZON GENOMICS S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Oryzon Genomics S.A.

Equities

ORY

ES0167733015

Market Closed - BME
Other stock markets
 11:35:03 2024-05-14 am EDT 		After market 12:27:17 pm
2.03 EUR +4.00% Intraday chart for Oryzon Genomics S.A. 2.03 0.00%
May. 06 Oryzon Genomics S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 22 Oryzon Genomics, S.A. Secures Another Important Patent for its Lead CNS Asset, Vafidemstat CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. ORY Stock
  4. Revisions Oryzon Genomics S.A.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW